HUANGSHAN-TOURISM
15.3.2023 12:29:42 CET | Business Wire | Press release
Huangshan Tourism recently made a stunning display at ITB Berlin 2023, which was held on March 7-9 in Germany. Hailed as one of the world's largest travel trade shows, this event brought together more than 5,500 exhibitors from over 160 countries and regions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230315005503/en/
Huangshan Tourism Receives Global Attention at ITB Berlin 2023 (Photo: Business Wire)
Huangshan Tourism presented a beautifully designed booth featuring scenic photos of Mount Huangshan, brochures, and touring routes, which was visited by numerous visitors, businessmen, and media representatives from around the world.
“Mount Huangshan's beautiful scenery is fascinating,” said Cornelia Bruchner, Chief Editor of Germany's Stegmedia. “I'm looking forward to visiting it in person and introducing more Germans to its beautiful scenery.”
Julian Elliot, a French landscape photographer, praised the magnificent Mount Huangshan landscape photos displayed at the booth, expressing his eagerness to visit the city, capture its beauty and share it with more people.
Mount Huangshan also attracted the interest of Peter Warren, Head of the promotion department of World Heritage, a magazine dedicated to introducing World Heritage sites inscribed by UNESCO. He expects the magazine to make Mount Huangshan known to a larger audience.
Libena Jarolimkova, from the Tourism Department of the Prague University of Economics and Business, said, “Mount Huangshan is more than a tourist destination. It has grown into a tourism complex that almost covers all sectors of the tourism industry, making it a good case study.”
As a scenic area, Huangshan Mountain is famous for its "Five Wonders" of pine trees, rocks, clouds, hot springs and boasts three world-renowned titles: World Cultural and Natural Heritage, UNESCO Global Geopark, and UNESCO Biosphere Reserve. Beneath the Huangshan Mountains lies the ancient city of Huangshan, formerly known as Huizhou, with its ancient villages such as Xidi and Hongcun, as well as its stunning landscapes such as Taiping Lake and Huashan World.
Huangshan Tourism has long been dedicated to cooperation and branding on the global stage. In recent years, Huangshan Tourism has participated in a series of activities such as New Year's countdown at New York Times Square, and London's Trafalgar New Year Celebration. This year witnessed the fourth participation of Huangshan Tourism in ITB Berlin as an effort to further promote the global image of Huangshan City while it is geared towards an ecological, international, and world-class leisure destination.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230315005503/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 01:00:00 CEST | Press release
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP-Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month-PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for pe
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 21:19:00 CEST | Press release
The offtake agreement connects Digital Reef’s 3.3 GW data centre pipeline with environmental assets from more than 30 million hectares of Amazon rainforest across South America, where Oreasoc Agriculture works directly on the ground alongside local communities to develop sustainable economies and safeguard their territories. Xange.com’s digital MRV technology monitors both the data centres and the rainforest. At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where D
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 15:00:00 CEST | Press release
Planned acquisition strengthens NetApp's position in the rapidly growing AI infrastructure market by bringing differentiated metadata innovation and parallel file architecture designed for AI NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata fr
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 14:57:00 CEST | Press release
The Group was recognised for the strength of its global institutional ecosystem and its contribution to financial markets innovation and community impact MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity
Croma-Pharma Introduces saypha® volume prime Lidocaine25.9.2026 14:04:00 CEST | Press release
New cross-linked hyaluronic acid filler replaces saypha® volume Lidocaine, offering physicians a more versatile solution for both midface volumization and nasolabial folds Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
